🔴 Biomea Fusion is trading 10.4% down with no confirmed catalyst

Biomea Fusion is trading at $0.75, down 10.40%, with no specific catalyst confirmed.

• No clear company announcement explaining the October 20 decline has been identified; its latest located release was October 13 Phase 1 BMF-650 data.
• The data showed weight reduction and encouraging tolerability, but available reporting does not establish it as the cause of the move.
• The biotech sector is up 2.10% and major indexes are higher, so broader market direction does not explain the drop.